Centrifugation affects the purity of liquid biopsy-based tumor biomarkers
- PMID: 30551256
- PMCID: PMC6590195
- DOI: 10.1002/cyto.a.23641
Centrifugation affects the purity of liquid biopsy-based tumor biomarkers
Abstract
Biomarkers in the blood of cancer patients include circulating tumor cells (CTCs), tumor-educated platelets (TEPs), tumor-derived extracellular vesicles (tdEVs), EV-associated miRNA (EV-miRNA), and circulating cell-free DNA (ccfDNA). Because the size and density of biomarkers differ, blood is centrifuged to isolate or concentrate the biomarker of interest. Here, we applied a model to estimate the effect of centrifugation on the purity of a biomarker according to published protocols. The model is based on the Stokes equation and was validated using polystyrene beads in buffer and plasma. Next, the model was applied to predict the biomarker behavior during centrifugation. The result was expressed as the recovery of CTCs, TEPs, tdEVs in three size ranges (1-8, 0.2-1, and 0.05-0.2 μm), EV-miRNA, and ccfDNA. Bead recovery was predicted with errors <18%. Most notable cofounders are the 22% contamination of 1-8 μm tdEVs for TEPs and the 8-82% contamination of <1 μm tdEVs for ccfDNA. A Stokes model can predict biomarker behavior in blood. None of the evaluated protocols produces a pure biomarker. Thus, care should be taken in the interpretation of obtained results, as, for example, results from TEPs may originate from co-isolated large tdEVs and ccfDNA may originate from DNA enclosed in <1 μm tdEVs. © 2018 The Authors. Cytometry Part A published by Wiley Periodicals, Inc. on behalf of International Society for Advancement of Cytometry.
Keywords: biomarker; centrifugation; circulating cell-free DNA; circulating tumor cells; exosomes; extracellular vesicles; flow cytometry; miRNA; microparticles; tumor-educated platelets.
© 2018 The Authors. Cytometry Part A published by Wiley Periodicals, Inc. on behalf of International Society for Advancement of Cytometry.
Conflict of interest statement
The authors declare that the research was carried out in the absence of any personal, professional, or financial relationship that could potentially be construed as a conflict of interest.
Figures


Similar articles
-
Phenotypic diversity of CTCs and tdEVs in liquid biopsies of tumour-draining veins is linked to poor prognosis in colorectal cancer.J Exp Clin Cancer Res. 2025 Jan 8;44(1):9. doi: 10.1186/s13046-024-03259-6. J Exp Clin Cancer Res. 2025. PMID: 39773651 Free PMC article.
-
Tumor-educated platelets.Blood. 2019 May 30;133(22):2359-2364. doi: 10.1182/blood-2018-12-852830. Epub 2019 Mar 4. Blood. 2019. PMID: 30833413 Review.
-
Pre-analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients.Mol Oncol. 2020 May;14(5):1001-1015. doi: 10.1002/1878-0261.12669. Epub 2020 Apr 4. Mol Oncol. 2020. PMID: 32246814 Free PMC article.
-
The Different Facets of Liquid Biopsy: A Kaleidoscopic View.Cold Spring Harb Perspect Med. 2020 Jun 1;10(6):a037333. doi: 10.1101/cshperspect.a037333. Cold Spring Harb Perspect Med. 2020. PMID: 31548226 Free PMC article. Review.
-
Evaluation of the liquid biopsy for the detection of BRAFV600E mutation in metastatic melanoma patients.Cancer Biomark. 2019;26(3):271-279. doi: 10.3233/CBM-181647. Cancer Biomark. 2019. PMID: 31524142
Cited by
-
Detection of extracellular vesicles in plasma and urine of prostate cancer patients by flow cytometry and surface plasmon resonance imaging.PLoS One. 2020 Jun 4;15(6):e0233443. doi: 10.1371/journal.pone.0233443. eCollection 2020. PLoS One. 2020. PMID: 32497056 Free PMC article.
-
Circulating platelets as liquid biopsy sources for cancer detection.Mol Oncol. 2021 Jun;15(6):1727-1743. doi: 10.1002/1878-0261.12859. Epub 2020 Dec 14. Mol Oncol. 2021. PMID: 33219615 Free PMC article. Review.
-
Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring.Mol Cancer. 2024 Jul 16;23(1):145. doi: 10.1186/s12943-024-02063-2. Mol Cancer. 2024. PMID: 39014366 Free PMC article. Review.
-
Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol.Cancers (Basel). 2019 Mar 30;11(4):458. doi: 10.3390/cancers11040458. Cancers (Basel). 2019. PMID: 30935089 Free PMC article.
-
Automated fluorescence gating and size determination reduce variation in measured concentration of extracellular vesicles by flow cytometry.Cytometry A. 2022 Dec;101(12):1049-1056. doi: 10.1002/cyto.a.24665. Epub 2022 Jun 28. Cytometry A. 2022. PMID: 35707999 Free PMC article.
References
-
- Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LWMM, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351:781–791. - PubMed
-
- de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LWWM, Pienta KJ, Raghavan D. Circulating tumor cells predict survival benefit from treatment in metastatic castration‐resistant prostate cancer. Clin Cancer Res 2008;14:6302–6309. - PubMed
-
- Cohen SJ, Punt CJA, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse MA, Mitchell E, Miller MC, et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol 2009;20:1223–1229. - PubMed
-
- Coumans FAW, Doggen CJM, Attard G, de Bono JS, Terstappen LWMM. All circulating Epcam+Ck+Cd45− objects predict overall survival in castration‐resistant prostate cancer. Ann Oncol 2010;21:1851–1857. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous